News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|April 10, 2024

Bronchiectasis Exacerbation Management

A medical professional explores the management of bronchiectasis exacerbations, detailing the significance of sputum color, the potential for hemoptysis, and the exacerbation of comorbidities such as COPD and asthma.

Episodes in this series

Video 1 - "Overview of Bronchiectasis"

EP. 1 Overview of Bronchiectasis

Video 2 - "Prognosis For Patients Diagnosed With Bronchiectasis"

EP. 2 Prognosis For Patients Diagnosed With Bronchiectasis

Video 3 - "Indicators Leading to Bronchiectasis Testing and Diagnosis"

EP. 3 Indicators Leading to Bronchiectasis Testing and Diagnosis

Video 3 - "Indicators Leading to Bronchiectasis Testing and Diagnosis"

EP. 4 Complications Associated With Bronchiectasis

Video 3 - "Indicators Leading to Bronchiectasis Testing and Diagnosis"

EP. 5 Current Treatment Options For Bronchiectasis

Video 6 - "Respiratory and Physical Therapists Contributing to Comprehensive Bronchiectasis Care"

EP. 6 Respiratory and Physical Therapists Contributing to Comprehensive Bronchiectasis Care

Video 7 - "Key Areas of Research and Emerging Therapies In Bronchiectasis Treatment"

EP. 7 Key Areas of Research and Emerging Therapies In Bronchiectasis Treatment

Video 1 - "Diagnosing and Understanding the Pathogenesis of Bronchiectasis"

EP. 8 Diagnosing and Understanding the Pathogenesis of Bronchiectasis

Video 2 - "Improving Long-Term Outlook: CT Scans and Underdiagnosis of Bronchiectasis"

EP. 9 Improving Long-Term Outlook: CT Scans and Underdiagnosis of Bronchiectasis

Video 10 - "Bronchiectasis Exacerbation Management"

EP. 10 Bronchiectasis Exacerbation Management

Video 11 - "Social Burden and Goals of Therapy for Patients with Bronchiectasis"

EP. 11 Social Burden and Goals of Therapy for Patients with Bronchiectasis

Video 11 - "Social Burden and Goals of Therapy for Patients with Bronchiectasis"

EP. 12 Patient Specific Factors: Guiding Treatment in Bronchiectasis

Video 13 - "Individualized Therapy for Specific Infections Associated with Bronchiectasis"

EP. 13 Individualized Therapy for Specific Infections Associated with Bronchiectasis

Pamela J. McShane, MD, an expert on bronchiectasis

EP. 14 Other Challenges With Bronchiectasis and Key Takeaways

Panagis Galiatsatos, MD, MHS, an expert on bronchiectasis

EP. 15 Identifying Bronchiectasis: Key Clinical Presentations to Consider

Panagis Galiatsatos, MD, MHS, an expert on bronchiectasis

EP. 16 Differentiating Bronchiectasis from COPD and Understanding Exacerbations

Panagis Galiatsatos, MD, MHS, an expert on bronchiectasis

EP. 17 Long-Term Impact of Bronchiectasis Exacerbations: Disease Progression, Patient Outcomes, and Economic Burden

Panagis Galiatsatos, MD, MHS, an expert on bronchiectasis

EP. 18 Managing Bronchiectasis: Treatment Goals, Outcome Measures, and Clinical Decision Resources

Panagis Galiatsatos, MD, MHS, an expert on bronchiectasis

EP. 19 Addressing Knowledge Gaps and Treatment Strategies in Bronchiectasis

Panagis Galiatsatos, MD, MHS, an expert on bronchiectasis

EP. 20 Challenges and Future Directions in Bronchiectasis Management

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Even After 6 Years, Disease Progression Impacts Survival in Mantle Cell Lymphoma

February 6th 2026

Acalabrutinib | Image Credit: © Сергей Шиманович-stocka.dobe.com.jpeg

Real-World Evidence Backs Acalabrutinib in CLL Care

ByMaggie L. Shaw

February 6th 2026

Debates at the International Stroke Conference 2026 centered on optimal treatment of ischemic stroke in the modern era. | Image credit: Aliaksandr Marko - stock.adobe.com

Is Less More After Thrombolysis? Debating Intensive Stroke Monitoring at ISC 2026

February 6th 2026

Dr Susan Vadaparampil

Linking Community Screening Programs to Cancer Centers Boosts Trial Diversity: Susan Vadaparampil, PhD, MPH

ByBrooke McCormick,Susan Vadaparampil, PhD, MPH

February 6th 2026

AJMC letter to the editor

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

ByFranco Nicolae Grados Rodriguez

February 6th 2026

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

Understanding Real-World MRI Utilization for ED Dizziness: Ava L. Liberman, MD

Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text